This is the authors' abstract. We don't add key points for this paper.
SEVERAL drugs that inhibit the replication of herpesvirus in vitro are now being evaluated for the prevention or treatment of infections with herpes simplex virus and varicella zoster virus.1 2 3 Two of these drugs, acyclovir or 9-[(2-hydroxyethoxy)-methyl]guanine and the thymidine analogue E-5-(2-bromovinyl)-2′deoxyuridine (BVDU), are the most efficient inhibitors of herpes simplex virus Type 1 plaque formation yet described.4 5 6 To inhibit the growth of herpes simplex virus and presumably that of varicella zoster virus, acyclovir and BVDU must first be phosphorylated to the respective monophosphates by virus-specified thymidine kinase and must then be converted by cellular enzymes to the respective triphosphates, . . .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Crumpacker et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: